Stockholm, Sweden

Ulrika Rosenström

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Rspr Pharma Ab. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrika Rosenström. Retrieved from https://idiyas.com/inventor/ulrika-rosenstrom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrika Rosenström: Innovator in Pharmaceutical Chemistry

Introduction

Ulrika Rosenström is a notable inventor based in Stockholm, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her work on pemirolast.

Latest Patents

Ulrika holds a patent for a crystalline form of pemirolast. This innovation involves a hemihydrate form of the sodium salt of pemirolast, which has potential applications in treating various medical conditions.

Career Highlights

Ulrika is associated with Rspr Pharma AB, where she has been instrumental in advancing research and development efforts. Her expertise in pharmaceutical formulations has positioned her as a key player in her field.

Collaborations

Ulrika collaborates with Anett Perlberg, who is also a talented professional in the pharmaceutical industry. Their partnership has fostered innovative approaches to drug development.

Conclusion

Ulrika Rosenström's contributions to pharmaceutical chemistry, particularly through her patent on pemirolast, highlight her role as an influential inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…